美股详情

本页面由Tiger Trade Technology Pte. Ltd.提供服务

万达生物制药

5.28

-0.1000-1.86%

盘后：5.26-0.0200-0.38%19:36 EDT

成交量：65.68万

成交额：349.81万

市值：3.19亿

市盈率：-1.14

高：5.42

开：5.42

低：5.27

收：5.38

52周最高：9.94

52周最低：4.27

股本：6,046.27万

流通股本：5,103.69万

量比：0.72

换手率：1.29%

股息：- -

股息率：- -

每股收益(TTM):-4.6291

每股收益(LYR):-3.7413

净资产收益率：-77.81%

总资产收益率：-22.38%

市净率：1.45

市盈率(LYR):-1.41

数据加载中...

总览公司新闻资讯公告

万达生物制药宣布Imsidolimab治疗GPP获欧洲药品管理局孤儿药资格积极意见

万达生物制药Imsidolimab治疗GPP的BLA申请获FDA受理，目标审评日期定于2026年12月12日

万达生物制药宣布其夏科-马里-图斯病2S型在研疗法获FDA儿科罕见病资格认定

日本授予Imsidolimab孤儿药资格，用于治疗泛发性脓疱型银屑病

万达生物制药宣布Nereus™（Tradipitant）在美国上市，系40余年来首款晕动症新药

万达生物制药：持有效处方患者可获Nereus药物现金支付价为每剂85美元

万达生物制药宣布Nereus™（Tradipitant）在美国上市，系四十余年来首款晕动症新药

BUZZ-旺达敦促美国食品药品管理局放弃延长药品审查时限的建议；股价下跌

万达生物制药敦促FDA撤回2027财年立法议程中延长药物审评时限的提案

万达生物制药启动Thetis研究：评估Nereus™预防GLP-1受体激动剂所致呕吐的临床试验

欧洲药品管理局人用药品委员会：确认拒绝Hetlioz（塔西美尔通）营销授权变更的建议

万达生物制药呼吁FDA加速推动动物试验向人体相关方法转型

欧洲药管局拒绝Hetlioz新增史密斯-马吉利斯综合征成人夜间睡眠障碍适应症的申请

Vanda Pharmaceuticals Inc.盘中异动大幅上涨5.07%报8.29美元

BUZZ-美国食品及药物管理局罕见地就时差药竞标举行听证会后，万达股价上涨

万达生物制药宣布美国FDA为Hetlioz®时差障碍适应症召开里程碑式听证会，系40余年来首次新药审批听证

EMA人用医药产品委员会：万达生物制药的伊洛哌酮获负面意见用于精神分裂症治疗

万达生物制药盘前股价上涨2.3%，FDA受理其罕见皮肤病药物审查申请

BUZZ-FDA接受罕见皮肤病药物审查申请，万达股价上涨

万达生物制药宣布美国FDA受理imsidolimab治疗泛发性脓疱型银屑病的生物制品许可申请

{"basename":"/hans","ssrTDKData":{"titleTemplate":"%s - 老虎证券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎证券,老虎证券开户,老虎券商,老虎证券官网,老虎证券app,tigertrade老虎证券,股票,炒股,新加坡股票交易平台,投资,投资理财","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hans/stock/VNDA/news"},"companyName":"老虎证券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"VNDA","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VNDA\",,,,,undefined,":{"symbol":"VNDA","market":"US","secType":"STK","nameCN":"万达生物制药","latestPrice":5.28,"timestamp":1787342400000,"preClose":5.38,"halted":0,"volume":656793,"hourTrading":{"tag":"盘后","latestPrice":5.26,"preClose":5.28,"latestTime":"19:36 EDT","volume":7082,"amount":37402.423,"timestamp":1787355398901,"change":-0.02,"changeRate":-0.003788,"amplitude":0.003788},"delay":0,"changeRate":-0.018587360594795474,"floatShares":51036899,"shares":60462687,"eps":-4.629083,"marketStatus":"未开盘","change":-0.1,"latestTime":"08-21 16:00:00 EDT","open":5.42,"high":5.42,"low":5.265,"amount":3498118.268787,"amplitude":0.02881,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-4.629083,"tradingStatus":0,"nextMarketStatus":{"tag":"盘前交易","tradingStatus":1,"beginTime":1787558400000},"marketStatusCode":0,"adr":0,"adrRate":0,"listingDate":1144814400000,"exchange":"NASDAQ","adjPreClose":5.38,"preHourTrading":{"tag":"盘前","latestPrice":5.38,"preClose":5.38,"latestTime":"08:45 EDT","volume":76,"amount":411.299992,"timestamp":1787316356132,"change":0,"changeRate":0,"amplitude":0.100372},"postHourTrading":{"tag":"盘后","latestPrice":5.26,"preClose":5.28,"latestTime":"19:36 EDT","volume":7082,"amount":37402.423,"timestamp":1787355398901,"change":-0.02,"changeRate":-0.003788,"amplitude":0.003788},"volumeRatio":0.7184991433423038,"impliedVol":0.4477,"impliedVolPercentile":0.2032},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"VNDA\",,,,,undefined,":{"symbol":"VNDA","floatShares":51036899,"roa":"-22.38%","roe":"-77.81%","lyrEps":-3.741276,"volumeRatio":0.7184991433423038,"shares":60462687,"dividePrice":0,"high":5.42,"amplitude":0.02881,"preClose":5.38,"low":5.265,"week52Low":4.27,"pbRate":"1.45","psRate":"1.48","week52High":9.94,"institutionHeld":0.7527,"latestPrice":5.28,"eps":-4.629083,"divideRate":0,"volume":656793,"delay":0,"ttmEps":-4.629083,"open":5.42,"prevYearClose":8.82,"prevWeekClose":5.22,"prevMonthClose":5.1,"prevQuarterClose":6.12,"fiveDayClose":5.22,"twentyDayClose":5.18,"sixtyDayClose":6.46},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/VNDA\",params:#limit:5,,,undefined,":[{"market":"US","date":"2026-08-05","symbol":"VNDA","fiscalQuarterEnding":"2026/06","expectedEps":-0.51,"name":null,"time":"盘后","type":"earning","dateTimestamp":1785902400000,"reportTimeType":"post","actualEps":-1.04},{"market":"US","date":"2026-05-06","symbol":"VNDA","fiscalQuarterEnding":"2026/03","expectedEps":-0.53,"name":null,"time":"盘后","type":"earning","dateTimestamp":1778040000000,"reportTimeType":"post","actualEps":-0.82},{"market":"US","date":"2026-02-11","symbol":"VNDA","fiscalQuarterEnding":"2025/12","expectedEps":-2.18,"name":null,"time":"盘后","type":"earning","dateTimestamp":1770786000000,"reportTimeType":"post","actualEps":-0.46},{"market":"US","date":"2025-10-29","symbol":"VNDA","fiscalQuarterEnding":"2025/09","expectedEps":-0.31,"name":null,"time":"盘后","type":"earning","dateTimestamp":1761710400000,"reportTimeType":"post","actualEps":-0.38},{"market":"US","date":"2025-07-31","symbol":"VNDA","fiscalQuarterEnding":"2025/06","expectedEps":-0.34,"name":null,"time":"盘前","type":"earning","dateTimestamp":1753934400000,"reportTimeType":"pre","actualEps":-0.46}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"VNDA\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"VNDA\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":0.75,"hold":0.25,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.75,"analysts":4,"updateTime":1772769600000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/VNDA\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"VNDA","date":"2026-08-21","current":-1.140615,"percent":0.451078,"low":-77.375491,"twenty":-6.417156,"median":17.635012,"eighty":50.47466,"high":127.111916,"avg":16.843106,"sd":36.133409,"marketCap":325289256},"quantilePoints":[{"date":"2021-08-27","current":29.6371,"twenty":-17.154068,"median":13.826448,"eighty":38.326403,"marketCap":961427508},{"date":"2021-09-03","current":28.71094,"twenty":-17.154068,"median":13.854535,"eighty":38.326403,"marketCap":931382898},{"date":"2021-09-10","current":27.76763,"twenty":-17.154068,"median":13.953851,"eighty":38.326403,"marketCap":900781907},{"date":"2021-09-17","current":29.071113,"twenty":-17.154068,"median":14.053167,"eighty":38.326403,"marketCap":943066913},{"date":"2021-09-24","current":29.602797,"twenty":-17.154068,"median":14.081124,"eighty":38.326403,"marketCap":960314745},{"date":"2021-10-01","current":30.494654,"twenty":-17.154068,"median":14.152482,"eighty":38.326403,"marketCap":989246591},{"date":"2021-10-08","current":31.026339,"twenty":-17.154068,"median":14.270959,"eighty":38.326403,"marketCap":1006494422},{"date":"2021-10-15","current":31.575174,"twenty":-17.154068,"median":14.301456,"eighty":38.326403,"marketCap":1024298636},{"date":"2021-10-22","current":31.386512,"twenty":-17.154068,"median":14.351114,"eighty":38.326403,"marketCap":1018178437},{"date":"2021-10-29","current":29.362682,"twenty":-17.154068,"median":14.4678,"eighty":38.326403,"marketCap":952525401},{"date":"2021-11-05","current":29.12112,"twenty":-17.154068,"median":14.798034,"eighty":38.326403,"marketCap":997806039},{"date":"2021-11-12","current":28.877224,"twenty":-17.154068,"median":14.798034,"eighty":38.326403,"marketCap":989449204},{"date":"2021-11-19","current":27.576448,"twenty":-17.154068,"median":14.798034,"eighty":38.326403,"marketCap":944879420},{"date":"2021-11-26","current":26.909801,"twenty":-17.154068,"median":14.798034,"eighty":38.326403,"marketCap":922037406},{"date":"2021-12-03","current":26.373231,"twenty":-17.154068,"median":14.798034,"eighty":38.326403,"marketCap":903652370},{"date":"2021-12-10","current":25.706583,"twenty":-17.154068,"median":14.798034,"eighty":38.326403,"marketCap":880810356},{"date":"2021-12-17","current":27.153696,"twenty":-17.154068,"median":14.798034,"eighty":38.326403,"marketCap":930394241},{"date":"2021-12-23","current":29.234937,"twenty":-17.154068,"median":14.798034,"eighty":38.326403,"marketCap":1001705895},{"date":"2021-12-31","current":25.511466,"twenty":-17.154068,"median":14.798034,"eighty":38.326403,"marketCap":874124888},{"date":"2022-01-07","current":25.007416,"twenty":-17.144215,"median":14.807432,"eighty":38.3263,"marketCap":856854097},{"date":"2022-01-14","current":24.389547,"twenty":-17.144215,"median":14.956751,"eighty":38.3263,"marketCap":835683450},{"date":"2022-01-21","current":23.072512,"twenty":-17.144215,"median":18.908459,"eighty":38.3263,"marketCap":790556543},{"date":"2022-01-28","current":23.966795,"twenty":-17.144215,"median":23.183837,"eighty":38.3263,"marketCap":821198270},{"date":"2022-02-04","current":19.560417,"twenty":-17.144215,"median":23.576563,"eighty":38.3263,"marketCap":670218126},{"date":"2022-02-11","current":21.983112,"twenty":-17.144215,"median":23.576563,"eighty":38.3263,"marketCap":753229349},{"date":"2022-02-18","current":21.804255,"twenty":-17.144215,"median":23.576563,"eighty":38.3263,"marketCap":747101004},{"date":"2022-02-25","current":18.853723,"twenty":-17.144215,"median":23.576563,"eighty":38.3263,"marketCap":625038638},{"date":"2022-03-04","current":18.280354,"twenty":-17.144215,"median":23.576563,"eighty":38.3263,"marketCap":606030308},{"date":"2022-03-11","current":18.786268,"twenty":-17.144215,"median":23.576563,"eighty":38.3263,"marketCap":622802364},{"date":"2022-03-18","current":20.287146,"twenty":-17.144215,"median":23.576563,"eighty":38.3263,"marketCap":672559465},{"date":"2022-03-25","current":19.32591,"twenty":-17.144215,"median":23.576563,"eighty":38.3263,"marketCap":640692558},{"date":"2022-04-01","current":19.94987,"twenty":-17.144215,"median":23.576563,"eighty":38.3263,"marketCap":661378094},{"date":"2022-04-08","current":19.916143,"twenty":-17.144215,"median":23.576563,"eighty":38.3263,"marketCap":660259957},{"date":"2022-04-14","current":19.157272,"twenty":-17.144215,"median":23.576563,"eighty":38.3263,"marketCap":635101872},{"date":"2022-04-22","current":18.448992,"twenty":-17.144215,"median":23.576563,"eighty":38.3263,"marketCap":611620993},{"date":"2022-04-29","current":16.903143,"twenty":-17.144215,"median":23.576563,"eighty":38.3263,"marketCap":560372983},{"date":"2022-05-06","current":30.007815,"twenty":-17.144215,"median":23.81234,"eighty":38.3263,"marketCap":542301235},{"date":"2022-05-13","current":31.289399,"twenty":-17.144215,"median":23.974925,"eighty":38.3263,"marketCap":565462017},{"date":"2022-05-20","current":31.008076,"twenty":-17.144215,"median":24.499553,"eighty":38.3263,"marketCap":560377943},{"date":"2022-05-27","current":31.94582,"twenty":-17.144215,"median":24.726466,"eighty":38.3263,"marketCap":577324856},{"date":"2022-06-03","current":31.727013,"twenty":-17.144215,"median":24.881125,"eighty":38.3263,"marketCap":573370576},{"date":"2022-06-10","current":30.539204,"twenty":-17.144215,"median":25.073094,"eighty":38.3263,"marketCap":551904486},{"date":"2022-06-17","current":29.914041,"twenty":-17.144215,"median":25.293157,"eighty":38.3263,"marketCap":540606543},{"date":"2022-06-24","current":33.446211,"twenty":-17.154068,"median":25.452351,"eighty":38.326403,"marketCap":604439918},{"date":"2022-07-01","current":34.97786,"twenty":-17.101725,"median":25.564724,"eighty":38.326403,"marketCap":632119877},{"date":"2022-07-08","current":36.759574,"twenty":-17.02494,"median":25.639639,"eighty":38.326403,"marketCap":664319013},{"date":"2022-07-15","current":35.853087,"twenty":-16.800559,"median":25.706583,"eighty":38.326403,"marketCap":647936996},{"date":"2022-07-22","current":34.29018,"twenty":-16.579017,"median":26.014214,"eighty":38.326403,"marketCap":619692140},{"date":"2022-07-29","current":33.696276,"twenty":-15.600428,"median":26.267051,"eighty":38.326403,"marketCap":608959095},{"date":"2022-08-05","current":54.282127,"twenty":3.791287,"median":26.340711,"eighty":38.356987,"marketCap":596723424},{"date":"2022-08-12","current":53.561796,"twenty":4.32242,"median":26.426246,"eighty":38.538084,"marketCap":588804819},{"date":"2022-08-19","current":53.253082,"twenty":4.487703,"median":26.576076,"eighty":38.789104,"marketCap":585411131},{"date":"2022-08-26","current":52.73856,"twenty":4.580888,"median":26.909801,"eighty":38.878336,"marketCap":579754985},{"date":"2022-09-02","current":53.407439,"twenty":4.668262,"median":27.104917,"eighty":38.971271,"marketCap":587107975},{"date":"2022-09-09","current":52.944369,"twenty":4.722768,"median":27.300033,"eighty":39.099148,"marketCap":582017443},{"date":"2022-09-16","current":51.246444,"twenty":4.761973,"median":27.45891,"eighty":39.345148,"marketCap":563352161},{"date":"2022-09-23","current":49.754329,"twenty":4.810183,"median":27.630421,"eighty":39.443307,"marketCap":546949337},{"date":"2022-09-30","current":50.834826,"twenty":4.836812,"median":27.76763,"eighty":39.543622,"marketCap":558827244},{"date":"2022-10-07","current":50.783374,"twenty":4.921115,"median":27.924545,"eighty":39.763436,"marketCap":558261629},{"date":"2022-10-14","current":50.47466,"twenty":4.941755,"median":28.024896,"eighty":39.984463,"marketCap":554867942},{"date":"2022-10-21","current":53.355987,"twenty":4.983255,"median":28.178057,"eighty":40.08767,"marketCap":586542360},{"date":"2022-10-28","current":54.590841,"twenty":5.012956,"median":28.291875,"eighty":40.302998,"marketCap":600117111},{"date":"2022-11-04","current":91.788849,"twenty":5.062961,"median":28.448949,"eighty":40.563626,"marketCap":595893205},{"date":"2022-11-11","current":93.27072,"twenty":5.093819,"median":28.590882,"eighty":40.972842,"marketCap":605513513},{"date":"2022-11-18","current":93.096382,"twenty":5.117101,"median":28.71094,"eighty":41.160269,"marketCap":604381712},{"date":"2022-11-25","current":90.91716,"twenty":5.138736,"median":28.748609,"eighty":41.266594,"marketCap":590234200},{"date":"2022-12-02","current":95.101267,"twenty":5.157046,"median":28.985358,"eighty":41.937708,"marketCap":617397423},{"date":"2022-12-09","current":91.614511,"twenty":5.176833,"median":29.071113,"eighty":42.119781,"marketCap":594761404},{"date":"2022-12-16","current":61.454072,"twenty":5.208554,"median":29.234937,"eighty":42.368145,"marketCap":398959838},{"date":"2022-12-23","current":59.885032,"twenty":5.239077,"median":29.511352,"eighty":43.046766,"marketCap":388773629},{"date":"2022-12-30","current":64.417815,"twenty":5.255617,"median":29.543872,"eighty":43.602452,"marketCap":418200454},{"date":"2023-01-06","current":64.679322,"twenty":5.277282,"median":29.6371,"eighty":43.9356,"marketCap":419898156},{"date":"2023-01-13","current":66.858544,"twenty":5.292197,"median":30.070331,"eighty":44.079494,"marketCap":434045668},{"date":"2023-01-20","current":65.725348,"twenty":5.315176,"median":30.184129,"eighty":48.044423,"marketCap":426688961},{"date":"2023-01-27","current":66.684206,"twenty":5.339308,"median":30.476687,"eighty":49.929267,"marketCap":432913867},{"date":"2023-02-03","current":66.684206,"twenty":5.359134,"median":30.528529,"eighty":50.515822,"marketCap":432913867},{"date":"2023-02-10","current":65.789461,"twenty":5.371292,"median":30.60172,"eighty":50.989183,"marketCap":412828869},{"date":"2023-02-17","current":63.889078,"twenty":5.395729,"median":30.726752,"eighty":51.812419,"marketCap":400903963},{"date":"2023-02-24","current":58.549906,"twenty":5.423851,"median":30.872928,"eighty":52.172585,"marketCap":367400658},{"date":"2023-03-03","current":57.644961,"twenty":5.475409,"median":30.940583,"eighty":52.779722,"marketCap":361722131},{"date":"2023-03-10","current":56.106556,"twenty":5.507294,"median":31.026339,"eighty":52.96495,"marketCap":352068636},{"date":"2023-03-17","current":59.002378,"twenty":5.539642,"median":31.129245,"eighty":53.139887,"marketCap":370239921},{"date":"2023-03-24","current":61.08375,"twenty":5.565634,"median":31.256083,"eighty":53.407439,"marketCap":383300532},{"date":"2023-03-31","current":61.445728,"twenty":5.591919,"median":31.406014,"eighty":53.726443,"marketCap":385571942},{"date":"2023-04-06","current":61.08375,"twenty":5.638122,"median":31.503027,"eighty":53.89109,"marketCap":383300532},{"date":"2023-04-14","current":62.803145,"twenty":5.715788,"median":31.776429,"eighty":54.282127,"marketCap":394089732},{"date":"2023-04-21","current":56.016061,"twenty":5.800167,"median":31.94582,"eighty":55.571109,"marketCap":351500784},{"date":"2023-04-28","current":56.757062,"twenty":5.889576,"median":32.228692,"eighty":56.160852,"marketCap":356150561},{"date":"2023-05-05","current":24.731543,"twenty":6.039467,"median":32.415379,"eighty":56.342329,"marketCap":394641234},{"date":"2023-05-12","current":22.319588,"twenty":6.525956,"median":32.447324,"eighty":56.360184,"marketCap":356153661},{"date":"2023-05-19","current":21.995594,"twenty":6.590821,"median":32.447324,"eighty":56.360184,"marketCap":350983689},{"date":"2023-05-26","current":21.563602,"twenty":6.773144,"median":32.447324,"eighty":56.360184,"marketCap":344090392},{"date":"2023-06-01","current":21.419604,"twenty":6.793305,"median":32.447324,"eighty":56.360184,"marketCap":341792627},{"date":"2023-06-09","current":23.399568,"twenty":7.081692,"median":32.455526,"eighty":56.453844,"marketCap":373386903},{"date":"2023-06-16","current":22.823578,"twenty":7.191261,"median":32.455526,"eighty":56.453844,"marketCap":364195841},{"date":"2023-06-23","current":23.147572,"twenty":7.30346,"median":32.473165,"eighty":56.605453,"marketCap":369365813},{"date":"2023-06-30","current":23.975557,"twenty":7.332386,"median":32.537703,"eighty":56.681257,"marketCap":382577965},{"date":"2023-07-07","current":23.651563,"twenty":7.360874,"median":32.602241,"eighty":56.757062,"marketCap":377407993},{"date":"2023-07-14","current":21.707599,"twenty":7.488413,"median":32.608258,"eighty":56.771752,"marketCap":346388158},{"date":"2023-07-21","current":23.039574,"twenty":7.560291,"median":32.653799,"eighty":56.801131,"marketCap":367642489},{"date":"2023-07-28","current":24.900298,"twenty":17.199629,"median":32.693323,"eighty":56.815821,"marketCap":371089137},{"date":"2023-08-04","current":21.763998,"twenty":17.370024,"median":32.473165,"eighty":56.272572,"marketCap":324348859},{"date":"2023-08-11","current":23.230366,"twenty":17.370024,"median":32.261499,"eighty":55.997962,"marketCap":346202151},{"date":"2023-08-18","current":22.535771,"twenty":17.370024,"median":31.94582,"eighty":54.55997,"marketCap":335850591},{"date":"2023-08-25","current":22.034118,"twenty":17.370024,"median":31.802888,"eighty":54.096899,"marketCap":328374465},{"date":"2023-09-01","current":20.027509,"twenty":17.370024,"median":31.503027,"eighty":53.757314,"marketCap":298469960},{"date":"2023-09-08","current":17.635012,"twenty":17.239057,"median":31.414833,"eighty":53.448601,"marketCap":262814589},{"date":"2023-09-15","current":18.329608,"twenty":17.226892,"median":31.272741,"eighty":53.253082,"marketCap":273166149},{"date":"2023-09-22","current":17.210537,"twenty":16.940417,"median":31.137821,"eighty":52.995821,"marketCap":256488636},{"date":"2023-09-29","current":16.824651,"twenty":16.932962,"median":31.041743,"eighty":52.851754,"marketCap":250737770},{"date":"2023-10-06","current":17.210537,"twenty":16.732038,"median":30.974885,"eighty":52.316651,"marketCap":256488636},{"date":"2023-10-13","current":16.747473,"twenty":16.670296,"median":30.914301,"eighty":52.06968,"marketCap":249587597},{"date":"2023-10-20","current":16.631708,"twenty":16.608555,"median":30.837677,"eighty":51.246444,"marketCap":247862337},{"date":"2023-10-27","current":16.940417,"twenty":16.539095,"median":30.726752,"eighty":50.824536,"marketCap":252463030},{"date":"2023-11-02","current":16.863239,"twenty":16.11462,"median":30.60172,"eighty":50.454079,"marketCap":251312857},{"date":"2023-11-10","current":16.521509,"twenty":16.014289,"median":30.520167,"eighty":49.754329,"marketCap":194458156},{"date":"2023-11-17","current":16.521509,"twenty":16.014289,"median":30.468519,"eighty":44.73022,"marketCap":194458156},{"date":"2023-11-24","current":17.401352,"twenty":16.014289,"median":30.189254,"eighty":43.977661,"marketCap":204813916},{"date":"2023-12-01","current":18.183436,"twenty":16.014289,"median":30.039073,"eighty":43.860074,"marketCap":214019036},{"date":"2023-12-08","current":19.405441,"twenty":16.11462,"median":29.6371,"eighty":43.094886,"marketCap":228402036},{"date":"2023-12-15","current":18.818878,"twenty":16.014289,"median":29.535742,"eighty":42.820094,"marketCap":221498196},{"date":"2023-12-21","current":18.574477,"twenty":15.983418,"median":29.511352,"eighty":42.218766,"marketCap":218621596},{"date":"2023-12-27","current":19.796482,"twenty":15.967983,"median":29.362682,"eighty":42.119781,"marketCap":233004595},{"date":"2024-01-05","current":20.676326,"twenty":14.280594,"median":29.131142,"eighty":41.900534,"marketCap":243360355},{"date":"2024-01-12","current":19.16104,"twenty":14.280594,"median":29.033964,"eighty":41.266594,"marketCap":225525436},{"date":"2024-01-19","current":18.036795,"twenty":12.624076,"median":28.933904,"eighty":41.111092,"marketCap":212293076},{"date":"2024-01-26","current":18.525597,"twenty":14.280594,"median":28.73835,"eighty":40.950245,"marketCap":218046276},{"date":"2024-02-02","current":18.232316,"twenty":14.280594,"median":28.702365,"eighty":40.554867,"marketCap":214594356},{"date":"2024-02-09","current":93.335042,"twenty":14.280594,"median":28.628365,"eighty":40.422302,"marketCap":234177620},{"date":"2024-02-16","current":100.214775,"twenty":14.280594,"median":28.628365,"eighty":40.499585,"marketCap":251438870},{"date":"2024-02-23","current":99.297477,"twenty":14.280594,"median":28.628365,"eighty":40.499585,"marketCap":249137370},{"date":"2024-03-01","current":102.508019,"twenty":15.937112,"median":28.665848,"eighty":40.503967,"marketCap":257192620},{"date":"2024-03-08","current":87.601931,"twenty":15.937112,"median":28.665848,"eighty":40.589905,"marketCap":219793246},{"date":"2024-03-15","current":87.143283,"twenty":15.937112,"median":28.665848,"eighty":41.040631,"marketCap":218642496},{"date":"2024-03-22","current":89.665851,"twenty":15.937112,"median":28.665848,"eighty":41.2026,"marketCap":224971621},{"date":"2024-03-28","current":89.207202,"twenty":15.937112,"median":28.665848,"eighty":41.767019,"marketCap":223820871},{"date":"2024-04-05","current":112.827619,"twenty":14.280594,"median":28.628365,"eighty":42.195037,"marketCap":283084495},{"date":"2024-04-12","current":98.150855,"twenty":14.280594,"median":28.628365,"eighty":43.126328,"marketCap":246260495},{"date":"2024-04-19","current":113.974241,"twenty":14.280594,"median":28.628365,"eighty":43.954144,"marketCap":285961370},{"date":"2024-04-26","current":102.737344,"twenty":15.937112,"median":28.665848,"eighty":44.091139,"marketCap":257767995},{"date":"2024-05-03","current":108.555431,"twenty":15.937112,"median":28.665848,"eighty":49.033997,"marketCap":272365577},{"date":"2024-05-10","current":-59.638647,"twenty":7.636989,"median":28.55658,"eighty":49.908686,"marketCap":291573347},{"date":"2024-05-17","current":-66.423883,"twenty":7.498932,"median":28.385069,"eighty":49.908686,"marketCap":324746363},{"date":"2024-05-24","current":-58.448255,"twenty":7.393745,"median":28.282163,"eighty":49.908686,"marketCap":285753520},{"date":"2024-05-31","current":-59.638647,"twenty":7.332386,"median":28.178057,"eighty":49.908686,"marketCap":291573347},{"date":"2024-06-07","current":-74.637589,"twenty":7.30609,"median":28.024896,"eighty":49.908686,"marketCap":364903171},{"date":"2024-06-14","current":-77.375491,"twenty":7.19915,"median":27.948994,"eighty":49.918976,"marketCap":378288774},{"date":"2024-06-21","current":-71.125932,"twenty":7.118945,"median":27.784781,"eighty":49.929267,"marketCap":347734681},{"date":"2024-06-28","current":-69.161785,"twenty":7.043123,"median":27.699025,"eighty":49.960138,"marketCap":338131966},{"date":"2024-07-05","current":-63.80502,"twenty":6.810836,"median":27.600837,"eighty":49.960138,"marketCap":311942743},{"date":"2024-07-12","current":-69.042746,"twenty":6.637716,"median":27.435935,"eighty":49.960138,"marketCap":337549983},{"date":"2024-07-15","current":-70.471216,"twenty":6.635525,"median":27.384481,"eighty":49.960138,"marketCap":344533776},{"date":"2024-08-02","current":-30.086439,"twenty":6.577672,"median":27.104917,"eighty":50.433498,"marketCap":328754517},{"date":"2024-08-09","current":-28.326062,"twenty":6.484758,"median":26.909801,"eighty":50.433498,"marketCap":309518880},{"date":"2024-08-16","current":-27.579236,"twenty":5.966713,"median":26.576076,"eighty":50.433498,"marketCap":301358307},{"date":"2024-08-23","current":-28.272717,"twenty":5.88344,"median":26.426246,"eighty":50.433498,"marketCap":308935982},{"date":"2024-08-30","current":-27.845959,"twenty":5.768902,"median":26.340711,"eighty":50.433498,"marketCap":304272797},{"date":"2024-09-06","current":-27.099133,"twenty":5.715788,"median":26.332602,"eighty":50.433498,"marketCap":296112224},{"date":"2024-09-13","current":-26.61903,"twenty":5.655719,"median":26.295145,"eighty":50.433498,"marketCap":290866141},{"date":"2024-09-20","current":-24.805309,"twenty":5.58998,"median":26.295145,"eighty":50.433498,"marketCap":271047607},{"date":"2024-09-27","current":-25.285411,"twenty":5.563517,"median":26.295145,"eighty":50.433498,"marketCap":276293689},{"date":"2024-10-04","current":-24.005137,"twenty":5.528419,"median":26.295145,"eighty":50.433498,"marketCap":262304136},{"date":"2024-10-11","current":-23.525035,"twenty":5.491943,"median":26.295145,"eighty":50.433498,"marketCap":257058053},{"date":"2024-10-18","current":-25.258739,"twenty":5.461327,"median":26.295145,"eighty":50.433498,"marketCap":276002240},{"date":"2024-10-25","current":-24.111827,"twenty":5.418839,"median":26.295145,"eighty":50.433498,"marketCap":263469932},{"date":"2024-10-31","current":-24.325206,"twenty":5.391868,"median":26.014214,"eighty":50.433498,"marketCap":265801524},{"date":"2024-11-08","current":-17.855433,"twenty":5.367499,"median":26.015518,"eighty":50.454079,"marketCap":292614836},{"date":"2024-11-15","current":-18.145688,"twenty":5.359134,"median":26.015518,"eighty":50.454079,"marketCap":297371534},{"date":"2024-11-22","current":-17.576411,"twenty":5.328527,"median":26.015518,"eighty":50.454079,"marketCap":288042231},{"date":"2024-11-29","current":-18.323587,"twenty":5.313305,"median":26.015518,"eighty":50.454079,"marketCap":300286941},{"date":"2024-12-06","current":-17.007135,"twenty":5.288291,"median":26.015518,"eighty":50.454079,"marketCap":278712928},{"date":"2024-12-13","current":-16.437858,"twenty":5.274959,"median":26.015518,"eighty":50.454079,"marketCap":269383625},{"date":"2024-12-20","current":-16.473438,"twenty":5.247835,"median":26.015518,"eighty":50.454079,"marketCap":269966706},{"date":"2024-12-27","current":-17.113874,"twenty":5.219777,"median":26.015518,"eighty":50.454079,"marketCap":280462172},{"date":"2025-01-03","current":-17.149454,"twenty":5.200137,"median":26.015518,"eighty":50.454079,"marketCap":281045254},{"date":"2025-01-10","current":-16.544598,"twenty":5.172047,"median":26.048037,"eighty":50.47466,"marketCap":271132869},{"date":"2025-01-17","current":-15.797422,"twenty":5.151955,"median":26.048037,"eighty":50.47466,"marketCap":258888159},{"date":"2025-01-24","current":-15.726263,"twenty":5.141617,"median":26.048037,"eighty":50.47466,"marketCap":257721996},{"date":"2025-01-31","current":-16.295539,"twenty":5.116334,"median":26.048037,"eighty":50.47466,"marketCap":267051299},{"date":"2025-02-07","current":-16.686917,"twenty":5.087903,"median":26.048037,"eighty":50.47466,"marketCap":273465195},{"date":"2025-02-14","current":-14.499909,"twenty":5.060621,"median":26.048037,"eighty":50.47466,"marketCap":274048276},{"date":"2025-02-21","current":-13.853917,"twenty":5.016797,"median":26.048037,"eighty":50.47466,"marketCap":261839037},{"date":"2025-02-28","current":-14.501873,"twenty":4.989699,"median":26.048037,"eighty":50.47466,"marketCap":274085406},{"date":"2025-03-07","current":-15.149829,"twenty":4.942936,"median":26.113076,"eighty":50.47466,"marketCap":286331776},{"date":"2025-03-14","current":-15.180684,"twenty":4.942346,"median":26.113076,"eighty":50.47466,"marketCap":286914936},{"date":"2025-03-21","current":-15.180684,"twenty":4.942346,"median":26.113076,"eighty":50.47466,"marketCap":286914936},{"date":"2025-03-28","current":-14.193323,"twenty":4.942346,"median":26.113076,"eighty":50.47466,"marketCap":268253802},{"date":"2025-04-04","current":-13.483657,"twenty":4.939984,"median":26.113076,"eighty":50.47466,"marketCap":254841112},{"date":"2025-04-11","current":-12.58886,"twenty":4.887176,"median":26.048037,"eighty":50.47466,"marketCap":237929459},{"date":"2025-04-17","current":-13.483657,"twenty":4.834368,"median":26.048037,"eighty":50.47466,"marketCap":254841112},{"date":"2025-04-25","current":-13.298526,"twenty":4.763966,"median":26.113076,"eighty":50.47466,"marketCap":251342149},{"date":"2025-05-02","current":-13.844808,"twenty":4.709103,"median":26.113076,"eighty":50.47466,"marketCap":261666880},{"date":"2025-05-09","current":-5.620625,"twenty":4.634656,"median":26.113076,"eighty":50.47466,"marketCap":248701404},{"date":"2025-05-16","current":-5.234418,"twenty":4.508876,"median":26.113076,"eighty":50.47466,"marketCap":231612514},{"date":"2025-05-23","current":-5.647311,"twenty":-5.223763,"median":26.113076,"eighty":50.47466,"marketCap":249882203},{"date":"2025-05-30","current":-5.847098,"twenty":-5.402239,"median":26.113076,"eighty":50.47466,"marketCap":258722375},{"date":"2025-06-06","current":-5.847098,"twenty":-5.740545,"median":26.113076,"eighty":50.47466,"marketCap":258722375},{"date":"2025-06-13","current":-6.166757,"twenty":-5.793821,"median":26.113076,"eighty":50.47466,"marketCap":272866651},{"date":"2025-06-20","current":-6.033565,"twenty":-5.913693,"median":26.178114,"eighty":50.47466,"marketCap":266973203},{"date":"2025-06-27","current":-6.41982,"twenty":-6.006927,"median":26.178114,"eighty":50.47466,"marketCap":284064203},{"date":"2025-07-03","current":-6.619607,"twenty":-6.105489,"median":26.178114,"eighty":50.47466,"marketCap":292904375},{"date":"2025-07-11","current":-6.646245,"twenty":-6.217369,"median":26.178114,"eighty":50.47466,"marketCap":294083065},{"date":"2025-07-18","current":-6.473097,"twenty":-6.382527,"median":26.178114,"eighty":50.47466,"marketCap":286421582},{"date":"2025-07-25","current":-6.379863,"twenty":-6.411829,"median":26.178114,"eighty":50.47466,"marketCap":282296168},{"date":"2025-08-01","current":-3.760546,"twenty":-6.411829,"median":26.178114,"eighty":50.47466,"marketCap":251719693},{"date":"2025-08-08","current":-3.707581,"twenty":-6.411829,"median":26.178114,"eighty":50.47466,"marketCap":248174346},{"date":"2025-08-15","current":-3.910615,"twenty":-6.411829,"median":26.178114,"eighty":50.47466,"marketCap":261764845},{"date":"2025-08-22","current":-3.981236,"twenty":-6.411829,"median":26.178114,"eighty":50.47466,"marketCap":266491976},{"date":"2025-08-29","current":-4.14896,"twenty":-6.411829,"median":26.178114,"eighty":50.47466,"marketCap":277718911},{"date":"2025-09-05","current":-4.095994,"twenty":-6.414492,"median":26.252526,"eighty":50.47466,"marketCap":274173563},{"date":"2025-09-12","current":-4.060684,"twenty":-6.411829,"median":26.178114,"eighty":50.47466,"marketCap":271809998},{"date":"2025-09-19","current":-3.990063,"twenty":-6.411829,"median":26.178114,"eighty":50.47466,"marketCap":267082867},{"date":"2025-09-26","current":-4.263718,"twenty":-6.411829,"median":26.178114,"eighty":50.47466,"marketCap":285400497},{"date":"2025-10-03","current":-4.555028,"twenty":-6.411829,"median":26.178114,"eighty":50.47466,"marketCap":304899910},{"date":"2025-10-10","current":-4.811028,"twenty":-6.411829,"median":26.178114,"eighty":50.47466,"marketCap":322035758},{"date":"2025-10-17","current":-4.652131,"twenty":-6.411829,"median":26.178114,"eighty":50.47466,"marketCap":311399715},{"date":"2025-10-24","current":-4.846338,"twenty":-6.411829,"median":26.178114,"eighty":50.47466,"marketCap":324399323},{"date":"2025-10-31","current":-3.031687,"twenty":-6.411829,"median":25.934219,"eighty":50.47466,"marketCap":255265041},{"date":"2025-11-07","current":-3.09524,"twenty":-6.411829,"median":25.511466,"eighty":50.47466,"marketCap":260616138},{"date":"2025-11-14","current":-3.04611,"twenty":-6.411829,"median":24.900298,"eighty":50.47466,"marketCap":256479374},{"date":"2025-11-21","current":-3.397044,"twenty":-6.411829,"median":24.407549,"eighty":50.47466,"marketCap":286027689},{"date":"2025-11-28","current":-3.762015,"twenty":-6.411829,"median":23.966795,"eighty":50.47466,"marketCap":316757936},{"date":"2025-12-05","current":-3.649716,"twenty":-6.411829,"median":23.820458,"eighty":50.47466,"marketCap":307302476},{"date":"2025-12-12","current":-4.632332,"twenty":-6.411829,"median":23.543565,"eighty":50.47466,"marketCap":390037758},{"date":"2025-12-19","current":-4.681463,"twenty":-6.411829,"median":23.399568,"eighty":50.47466,"marketCap":394174522},{"date":"2025-12-26","current":-4.849912,"twenty":-6.411829,"median":23.307544,"eighty":50.47466,"marketCap":408357713},{"date":"2026-01-02","current":-6.190481,"twenty":-6.411829,"median":23.230366,"eighty":50.47466,"marketCap":521232276},{"date":"2026-01-09","current":-5.151715,"twenty":-6.411829,"median":23.072512,"eighty":50.47466,"marketCap":433769264},{"date":"2026-01-16","current":-5.228921,"twenty":-6.411829,"median":23.003575,"eighty":50.47466,"marketCap":440269893},{"date":"2026-01-23","current":-5.685135,"twenty":-6.411829,"median":22.921657,"eighty":50.47466,"marketCap":478682703},{"date":"2026-01-30","current":-5.460537,"twenty":-6.411829,"median":22.75158,"eighty":50.47466,"marketCap":459771781},{"date":"2026-02-06","current":-5.07451,"twenty":-6.411829,"median":22.61724,"eighty":50.47466,"marketCap":427268634},{"date":"2026-02-13","current":-1.640743,"twenty":-6.411829,"median":22.571583,"eighty":50.47466,"marketCap":361741143},{"date":"2026-02-20","current":-1.635381,"twenty":-6.411829,"median":22.405864,"eighty":50.47466,"marketCap":360558983},{"date":"2026-02-27","current":-2.305619,"twenty":-6.411829,"median":22.304239,"eighty":50.47466,"marketCap":508329058},{"date":"2026-03-06","current":-2.120633,"twenty":-6.411829,"median":22.093852,"eighty":50.47466,"marketCap":467544517},{"date":"2026-03-13","current":-2.490605,"twenty":-6.411829,"median":21.983112,"eighty":50.47466,"marketCap":549113598},{"date":"2026-03-20","current":-2.297576,"twenty":-6.411829,"median":21.804255,"eighty":50.47466,"marketCap":506555817},{"date":"2026-03-27","current":-1.908838,"twenty":-6.411829,"median":21.609139,"eighty":50.47466,"marketCap":420849173},{"date":"2026-04-02","current":-1.895433,"twenty":-6.411829,"median":21.462802,"eighty":50.47466,"marketCap":417893772},{"date":"2026-04-10","current":-1.965138,"twenty":-6.411829,"median":21.223757,"eighty":50.47466,"marketCap":433261859},{"date":"2026-04-17","current":-1.919562,"twenty":-6.411829,"median":20.676326,"eighty":50.47466,"marketCap":423213494},{"date":"2026-04-24","current":-1.793557,"twenty":-6.411829,"median":20.051053,"eighty":50.47466,"marketCap":395432720},{"date":"2026-05-01","current":-1.93655,"twenty":-6.411829,"median":19.899279,"eighty":50.47466,"marketCap":426958940},{"date":"2026-05-08","current":-1.604124,"twenty":-6.411829,"median":19.718799,"eighty":50.47466,"marketCap":384263046},{"date":"2026-05-15","current":-1.604137,"twenty":-6.411829,"median":19.477684,"eighty":50.47466,"marketCap":384266241},{"date":"2026-05-22","current":-1.55895,"twenty":-6.411829,"median":19.393365,"eighty":50.47466,"marketCap":373441840},{"date":"2026-05-29","current":-1.666897,"twenty":-6.414492,"median":19.317478,"eighty":50.47466,"marketCap":399300131},{"date":"2026-06-05","current":-1.568992,"twenty":-6.411829,"median":19.16104,"eighty":50.47466,"marketCap":375847262},{"date":"2026-06-12","current":-1.531336,"twenty":-6.411829,"median":19.10668,"eighty":50.47466,"marketCap":366826928},{"date":"2026-06-18","current":-1.496191,"twenty":-6.411829,"median":18.97177,"eighty":50.47466,"marketCap":358407949},{"date":"2026-06-26","current":-1.468576,"twenty":-6.414492,"median":18.818878,"eighty":50.47466,"marketCap":351793037},{"date":"2026-07-02","current":-1.518784,"twenty":-6.414492,"median":18.735677,"eighty":50.47466,"marketCap":363820150},{"date":"2026-07-10","current":-1.601627,"twenty":-6.414492,"median":18.562326,"eighty":50.47466,"marketCap":383664885},{"date":"2026-07-17","current":-1.368161,"twenty":-6.414492,"median":18.382265,"eighty":50.47466,"marketCap":327738812},{"date":"2026-07-24","current":-1.345567,"twenty":-6.414492,"median":18.329608,"eighty":50.47466,"marketCap":322326612},{"date":"2026-07-31","current":-1.30038,"twenty":-6.417156,"median":18.232316,"eighty":50.47466,"marketCap":311502211},{"date":"2026-08-07","current":-1.11912,"twenty":-6.417156,"median":18.036795,"eighty":50.47466,"marketCap":307593399},{"date":"2026-08-14","current":-1.106509,"twenty":-6.417156,"median":17.841274,"eighty":50.47466,"marketCap":304127315},{"date":"2026-08-21","current":-1.183503,"twenty":-6.417156,"median":17.635012,"eighty":50.47466,"marketCap":325289256}],"updateTime":1787536602819},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"VNDA\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"1111995389","title":"万达生物制药宣布Imsidolimab治疗GPP获欧洲药品管理局孤儿药资格积极意见","url":"https://stock-news.laohu8.com/highlight/detail?id=1111995389","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1111995389?lang=zh_cn&edition=fundamental","pubTime":"2026-07-17 04:31","pubTimestamp":1784233875,"startTime":"0","endTime":"0","summary":"万达生物制药宣布，其候选药物Imsidolimab用于治疗泛发性脓疱型银屑病（GPP）的孤儿药资格申请，已获得欧洲药品管理局（EMA）人用药品委员会（CHMP）的积极意见。\n孤儿药资格旨在鼓励针对罕见疾病的药物开发。获得EMA的积极意见是Imsidolimab在欧洲监管路径上的一个重要进展，为其后续的上市申请奠定了基础。这一进展有望为GPP患者带来新的治疗希望。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VNDA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130581087","title":"万达生物制药Imsidolimab治疗GPP的BLA申请获FDA受理，目标审评日期定于2026年12月12日","url":"https://stock-news.laohu8.com/highlight/detail?id=1130581087","media":"美股速递","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130581087?lang=zh_cn&edition=fundamental","pubTime":"2026-07-17 04:31","pubTimestamp":1784233873,"startTime":"0","endTime":"0","summary":"万达生物制药（Vanda Pharmaceuticals）用于治疗泛发性脓疱型银屑病（GPP）的候选药物Imsidolimab的生物制品许可申请（BLA），目前正处于美国食品药品监督管理局（FDA）的审评流程中。FDA已为该申请设定了目标审评日期，定为2026年12月12日。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","VNDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1143586895","title":"万达生物制药宣布其夏科-马里-图斯病2S型在研疗法获FDA儿科罕见病资格认定","url":"https://stock-news.laohu8.com/highlight/detail?id=1143586895","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1143586895?lang=zh_cn&edition=fundamental","pubTime":"2026-07-08 04:31","pubTimestamp":1783456277,"startTime":"0","endTime":"0","summary":"万达生物制药近日宣布，其针对夏科-马里-图斯病2S型（Charcot-Marie-Tooth Disease Type 2S）的在研疗法，已获得美国食品药品监督管理局（FDA）授予的儿科罕见病资格认定。这一认定标志着该疗法在针对这一罕见儿科疾病的研究与开发进程中取得了重要进展。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VNDA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1108747012","title":"日本授予Imsidolimab孤儿药资格，用于治疗泛发性脓疱型银屑病","url":"https://stock-news.laohu8.com/highlight/detail?id=1108747012","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1108747012?lang=zh_cn&edition=fundamental","pubTime":"2026-05-27 19:07","pubTimestamp":1779880037,"startTime":"0","endTime":"0","summary":"日本监管机构已授予万达生物制药旗下在研药物Imsidolimab孤儿药资格，用于治疗泛发性脓疱型银屑病。\n这一认定旨在鼓励针对罕见疾病的药物开发，可能为该药未来在日本市场的审批与商业化提供路径支持。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","VNDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1172511226","title":"万达生物制药宣布Nereus™（Tradipitant）在美国上市，系40余年来首款晕动症新药","url":"https://stock-news.laohu8.com/highlight/detail?id=1172511226","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1172511226?lang=zh_cn&edition=fundamental","pubTime":"2026-05-04 20:03","pubTimestamp":1777896224,"startTime":"0","endTime":"0","summary":"万达生物制药近日宣布，其研发的Nereus™（Tradipitant）已正式在美国市场投入商业销售。该药物成为四十多年来首款针对晕动症患者的新型药理治疗方案，标志着晕动症治疗领域迎来重大突破。\n此次上市意味着长期受晕动症困扰的患者将获得全新的治疗选择。Nereus™的推出不仅填补了该领域数十年的技术空白，更展现了医药创新对提升人类生活质量的持续推动力。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VNDA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1116493607","title":"万达生物制药：持有效处方患者可获Nereus药物 现金支付价为每剂85美元","url":"https://stock-news.laohu8.com/highlight/detail?id=1116493607","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1116493607?lang=zh_cn&edition=fundamental","pubTime":"2026-05-02 04:38","pubTimestamp":1777667891,"startTime":"0","endTime":"0","summary":"万达生物制药宣布，持有合规处方的患者现可通过现金支付方式获取Nereus药物，单剂定价为85美元。该方案为患者提供了直接购买渠道，无需经过传统保险报销流程。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VNDA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1140245743","title":"万达生物制药宣布Nereus™（Tradipitant）在美国上市，系四十余年来首款晕动症新药","url":"https://stock-news.laohu8.com/highlight/detail?id=1140245743","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1140245743?lang=zh_cn&edition=fundamental","pubTime":"2026-05-02 04:37","pubTimestamp":1777667841,"startTime":"0","endTime":"0","summary":"美国医药市场迎来突破性进展——万达生物制药旗下新型晕动症治疗药物Nereus正式启动商业销售。这款神经激肽-1受体拮抗剂成为四十多年来首个针对晕动症的创新药理疗法，标志着该领域治疗空白终被填补。临床研究显示，口服Nereus能有效阻断引发恶心呕吐的关键神经信号通路。值得注意的是，该药物曾于2023年完成三期临床试验，数据显示用药组晕动症状发生率降低超70%。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VNDA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2626363151","title":"BUZZ-旺达敦促美国食品药品管理局放弃延长药品审查时限的建议；股价下跌","url":"https://stock-news.laohu8.com/highlight/detail?id=2626363151","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2626363151?lang=zh_cn&edition=fundamental","pubTime":"2026-04-09 23:20","pubTimestamp":1775748002,"startTime":"0","endTime":"0","summary":"由于自动化翻译可能有误，或未能包含所需语境，路透不保证自动化翻译文本的准确性，仅是为了便利读者而提供自动化翻译。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260409:nL4T40S1EH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","VNDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1154480528","title":"万达生物制药敦促FDA撤回2027财年立法议程中延长药物审评时限的提案","url":"https://stock-news.laohu8.com/highlight/detail?id=1154480528","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1154480528?lang=zh_cn&edition=fundamental","pubTime":"2026-04-09 23:04","pubTimestamp":1775747053,"startTime":"0","endTime":"0","summary":"万达生物制药（Vanda Pharmaceuticals）近日呼吁美国食品药品监督管理局（FDA）从其2027财年立法议程中撤销一项旨在延长药物审评时间表的提案。该公司认为，此举可能对药物研发进程产生不利影响。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VNDA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1118743082","title":"万达生物制药启动Thetis研究：评估Nereus™预防GLP-1受体激动剂所致呕吐的临床试验","url":"https://stock-news.laohu8.com/highlight/detail?id=1118743082","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1118743082?lang=zh_cn&edition=fundamental","pubTime":"2026-04-09 04:46","pubTimestamp":1775681177,"startTime":"0","endTime":"0","summary":"万达生物制药宣布正式启动名为\"Thetis研究\"的临床试验，该试验旨在评估其创新药物Nereus对GLP-1受体激动剂引发的呕吐症状的预防效果。这项研究将针对使用GLP-1受体激动剂治疗时出现胃肠道不良反应的患者群体，探索Nereus在控制药物相关性呕吐方面的潜在疗效。若试验结果积极，Nereus有望成为首款专门针对GLP-1类药物相关呕吐症状的预防性疗法，为全球数百万相关患者提供新的解决方案。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","VNDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146656831","title":"欧洲药品管理局人用药品委员会：确认拒绝Hetlioz（塔西美尔通）营销授权变更的建议","url":"https://stock-news.laohu8.com/highlight/detail?id=1146656831","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146656831?lang=zh_cn&edition=fundamental","pubTime":"2026-03-27 19:45","pubTimestamp":1774611912,"startTime":"0","endTime":"0","summary":"欧洲药品管理局人用药品委员会（CHMP）已确认其建议，拒绝批准对Hetlioz（塔西美尔通）营销授权的变更申请。该决定维持了委员会早前的立场，意味着相关制药公司——万达生物制药（Vanda Pharmaceuticals）——此次申请未获通过。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VNDA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1106740354","title":"万达生物制药呼吁FDA加速推动动物试验向人体相关方法转型","url":"https://stock-news.laohu8.com/highlight/detail?id=1106740354","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1106740354?lang=zh_cn&edition=fundamental","pubTime":"2026-03-20 04:37","pubTimestamp":1773952632,"startTime":"0","endTime":"0","summary":"万达生物制药近日公开敦促美国食品药品监督管理局采取实质性行动，加快医药研发领域从传统动物试验向更具人体相关性的替代方法转变。该公司指出，当前基于人类生物学的新型检测技术已展现出更精准预测药物反应的潜力，此举将有望重构药物安全评估体系，提升临床转化效率。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VNDA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1152286791","title":"欧洲药管局拒绝Hetlioz新增史密斯-马吉利斯综合征成人夜间睡眠障碍适应症的申请","url":"https://stock-news.laohu8.com/highlight/detail?id=1152286791","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1152286791?lang=zh_cn&edition=fundamental","pubTime":"2026-03-18 00:17","pubTimestamp":1773764233,"startTime":"0","endTime":"0","summary":"欧洲药品管理局近日正式否决了关于拓展Hetlioz（塔司普雷酮）营销授权的申请，该申请旨在将史密斯-马吉利斯综合征成人患者的夜间睡眠障碍纳入治疗范围。此次决定意味着由万达生物制药开发的这款褪黑素受体激动剂暂无法在欧洲市场扩大其临床适用范围。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VNDA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2618675841","title":"Vanda Pharmaceuticals Inc.盘中异动 大幅上涨5.07%报8.29美元","url":"https://stock-news.laohu8.com/highlight/detail?id=2618675841","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2618675841?lang=zh_cn&edition=fundamental","pubTime":"2026-03-09 23:33","pubTimestamp":1773070438,"startTime":"0","endTime":"0","summary":"北京时间2026年03月09日23时33分，Vanda Pharmaceuticals Inc.股票出现波动，股价急速拉升5.07%。Vanda Pharmaceuticals Inc.股票所在的生物技术行业中，整体涨幅为0.50%。Vanda Pharmaceuticals Inc.公司简介：万达生物制药有限公司是一家生物制药公司，该公司致力于开发和商业化疗法，以满足大量未满足的医疗需求，并改善患者的生活。大部分收入来自 Fanapt 产品销售。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030923335897ab39f2&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2026030923335897ab39f2&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["VNDA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2616323680","title":"BUZZ-美国食品及药物管理局罕见地就时差药竞标举行听证会后，万达股价上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2616323680","media":"路透中文","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2616323680?lang=zh_cn&edition=fundamental","pubTime":"2026-03-03 21:36","pubTimestamp":1772544987,"startTime":"0","endTime":"0","summary":"BUZZ-美国食品及药物管理局罕见地就时差药竞标举行听证会后，万达股价上涨3月3日 - ** 制药商万达制药VNDA.O股价盘前上涨2.2%至8.35美元** 公司称美国食品药品管理局将举行罕见的公开听证会，审查其扩大睡眠药物Hetlioz治疗时差紊乱的申请** 当长途旅行扰乱了人体的内部时钟，导致疲劳和睡眠不佳时，就会出现时差现象。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260303:nL4T3ZR19F:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","VNDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1146152400","title":"万达生物制药宣布美国FDA为Hetlioz®时差障碍适应症召开里程碑式听证会，系40余年来首次新药审批听证","url":"https://stock-news.laohu8.com/highlight/detail?id=1146152400","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1146152400?lang=zh_cn&edition=fundamental","pubTime":"2026-03-03 21:04","pubTimestamp":1772543085,"startTime":"0","endTime":"0","summary":"万达生物制药宣布，美国食品药品监督管理局已为其药物Hetlioz®用于治疗时差障碍的申请召开了一次具有里程碑意义的听证会。此次听证会是FDA超过40年来首次针对新药审批举行的听证会，标志着监管程序的一个重要突破。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VNDA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1119330741","title":"EMA人用医药产品委员会：万达生物制药的伊洛哌酮获负面意见 用于精神分裂症治疗","url":"https://stock-news.laohu8.com/highlight/detail?id=1119330741","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1119330741?lang=zh_cn&edition=fundamental","pubTime":"2026-02-27 18:54","pubTimestamp":1772189699,"startTime":"0","endTime":"0","summary":"欧洲药品管理局人用医药产品委员会对万达生物制药旗下药物伊洛哌酮治疗精神分裂症的申请出具了否定性评估意见。该决定意味着该药物现阶段未获得委员会推荐批准。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","VNDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1138725313","title":"万达生物制药盘前股价上涨2.3%，FDA受理其罕见皮肤病药物审查申请","url":"https://stock-news.laohu8.com/highlight/detail?id=1138725313","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1138725313?lang=zh_cn&edition=fundamental","pubTime":"2026-02-25 21:39","pubTimestamp":1772026751,"startTime":"0","endTime":"0","summary":"万达生物制药股价在盘前交易中录得2.3%的上涨，此前美国食品药品监督管理局已正式受理该公司针对罕见皮肤病药物的审查申请。这一进展标志着该药物在监管审批流程中迈出了关键一步，为后续可能的市场准入奠定了基础。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","VNDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2614082897","title":"BUZZ-FDA接受罕见皮肤病药物审查申请，万达股价上涨","url":"https://stock-news.laohu8.com/highlight/detail?id=2614082897","media":"路透中文","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2614082897?lang=zh_cn&edition=fundamental","pubTime":"2026-02-25 20:53","pubTimestamp":1772024027,"startTime":"0","endTime":"0","summary":"BUZZ-FDA接受罕见皮肤病药物审查申请，万达股价上涨2月25日 - ** 万达制药VNDA.O股价盘前上涨5.39%，报8.61美元 ** 制药商称美国FDA接受了其对imsidolimab的审查申请，该药用于治疗泛发性脓疱型银屑病，一种会导致皮肤出现疼痛脓疱、发烧和疲劳的罕见疾病。对于因为使用自动化翻译功能而造成的任何损害或损失，路透不承担任何责任。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260225:nL4T3ZL16T:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","VNDA"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1130498462","title":"万达生物制药宣布美国FDA受理imsidolimab治疗泛发性脓疱型银屑病的生物制品许可申请","url":"https://stock-news.laohu8.com/highlight/detail?id=1130498462","media":"投资观察","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1130498462?lang=zh_cn&edition=fundamental","pubTime":"2026-02-25 20:41","pubTimestamp":1772023308,"startTime":"0","endTime":"0","summary":"万达生物制药公司宣布，美国食品药品监督管理局已正式受理其候选药物imsidolimab用于治疗泛发性脓疱型银屑病的生物制品许可申请。\nFDA已为该申请设定了目标审评日期为2026年12月12日。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["VNDA","BK4139"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":2,"pageCount":1,"totalSize":21,"code":"91000000","status":"200"}]}}